PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1494869
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1494869
According to Stratistics MRC, the Global Contrast Enhanced Digital Mammography (CEDM) Market is accounted for $462.59 million in 2024 and is expected to reach $952.91 million by 2030 growing at a CAGR of 12.8% during the forecast period. Contrast-Enhanced Digital Mammography (CEDM) is an advanced imaging technique used in breast cancer screening and diagnosis. It involves the injection of a contrast agent into the patient's bloodstream, which highlights abnormal blood vessels in breast lesions. This enhances the visibility of suspicious areas on mammograms, particularly in cases where traditional mammography may be inconclusive. CEDM combines the benefits of digital mammography with contrast-enhanced imaging, offering improved sensitivity for detecting breast cancer, especially in dense breast tissue.
According to the U.S. Breast Cancer Statistics, about 1 in 8 women in the U.S. (about 12.4%) would develop invasive breast cancer over the course of her lifetime. Breast cancer, which makes up around 35% of all occurrences of female cancer in Asia, is the most frequent cancer among women, according to the World Health Organization.
Time efficient process
A digital mammography is renowned for its quick results, which are available right away for the doctors to review. There is no requirement to spend time on film developing as there would be in a conventional process. During the examination, the technician can see the results on the computer screen. They can also be altered to magnify and concentrate on specific locations. It is also feasible to alter the contrast to distinguish between normal and diseased breast tissues. As a result, this is the main element fueling the market's expansion.
Reduced spatial resolution
Digital mammography also has a function with a lower spatial resolution. The projected calcification images are elevated above the lowest resolution limit by the digital geometric magnification. The fact that the picture magnification power on the monitor is not a substitute for true geometric magnification with better focus is another problem. As a result, this factor is preventing the market from expanding.
Advent of new technology
The death rate from breast cancer is projected to decrease as a result of technological developments in CEDM and several government campaigns to raise awareness. In thick breasts, however, the introduction of contrast-enhanced digital mammography enhances cancer diagnosis. The introduction of breast cancer screening programmes worldwide and the rise in breast cancer prevalence have fuelled the market's expansion.
High cost
The price of a digital mammography is more than one using traditional film. The procedure's time savings would cover this cost for the improved facilities. However, research falls short of demonstrating the advantages of breast cancer detection. Additionally, there is a lower chance of a contrast allergic reaction and a higher radiation dose compared to traditional mammography. Contrast-enhanced mammography solutions are hindering the market's growth because breast MR is more time-consuming, expensive, and uncomfortable for patients.
The market has been adversely affected by the COVID-19 pandemic. Globally, the pandemic led to significant declines in breast cancer screening, cancer management visits, and cancer operations. Due to the lockdown measures in several nations and the delays in manufacturing and production of a wide variety of X-ray imaging devices, including mammography systems, the pandemic epidemic has had an impact on the growth of the business for mammography systems.
The diagnosis segment is expected to be the largest during the forecast period
The diagnosis segment in the Contrast Enhanced Digital Mammography (CEDM) market has witnessed notable growth due to advancements in imaging technology and an increasing emphasis on early detection of breast cancer. CEDM offers enhanced contrast and improved lesion detection capabilities compared to traditional mammography, driving its adoption in diagnostic procedures. Additionally, rising awareness about the importance of early diagnosis and the need for more accurate imaging modalities has spurred demand for CEDM systems. With a growing patient pool and healthcare providers prioritizing efficient diagnostic tools, the diagnosis segment in the CEDM market is poised for continued growth.
The hospitals segment is expected to have the highest CAGR during the forecast period
The hospital segment within the Contrast Enhanced Digital Mammography (CEDM) market has witnessed significant growth in recent years. With advancements in technology and increasing awareness about the importance of early detection of breast cancer, hospitals have been increasingly adopting CEDM systems. Additionally, the integration of CEDM into hospital settings provides patients with access to comprehensive breast imaging services under one roof, contributing to the segment's growth. Favourable reimbursement policies and government initiatives aimed at improving breast cancer screening have further propelled the adoption of CEDM in hospitals.
North America is projected to hold the largest market share during the forecast period owing to high prevalence and increase in incidence of breast cancer. Some of the key factors anticipated to propel the market growth include the rising adoption of advanced diagnostic techniques for breast malignancy detection in the region, the superiority of contrast-enhanced digital mammography over the traditional MRI technique, rising incidence of breast cancer, and growing awareness of early detection and screening of breast cancer.
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to various initiatives taken by private and government institutions to provide better health care facilities. Low cost of contrast-enhanced digital mammography, quicker procedure time compared to standard MRI, and a sharp increase in the number of breast cancer patients in the area. Government programmes offering free cancer screenings are also propelling the industry.
Key players in the market
Some of the key players in Contrast Enhanced Digital Mammography (CEDM) market include Allengers Medical Systems Limited, Bmi Biomedical International S.R.L., Carestream Health, Gamma Medica, Inc., GE Healthcare, Hologic Inc., Konica Minolta, Inc., Koninklijke Philips N.V., Metaltronica S.p.A, Planmed Oy, Siemens Healthcare GmbH, Toshiba Medical Systems and Villa Systems Medical SpA.
In May 2024, Konica Minolta, Inc. has been actively working to use recycled plastics, which contribute to a recycling-oriented society. Leveraging its know-how of high-functionality recycling, the Company has started supplying recycled plastics derived from used polycarbonate (PC) water bottles through joint development with NEC Platforms, Ltd. (NEC Platforms) for exterior parts of an Aterm home Wi-Fi router manufactured by NEC Platforms.
In November 2023, Toshiba Medical Systems Europe is launching a new 80-row multislice CT scanner, called Aquilion Prime SP, at next week's U.K. Radiological Congress (UKRC) in Manchester. Aquilion Prime SP includes a number of Toshiba technologies designed to meet increasing demands for superior imaging and outstanding economic performance, according to the company. It includes technologies such as Toshiba's PureVision Optics mode, which makes up to 40% more efficient use of x-rays.